Ascend Wellness Holdings (AAWH) Cash & Equivalents (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Cash & Equivalents of $60.9 million for Q1 2026, down 39.1% year-over-year from $100.0 million in Q1 2025, and down 28.89% quarter-over-quarter from $85.7 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Cash & Equivalents (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $60.9 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 39.1% year-over-year to $60.9 million; the TTM figure through Mar 2026 stood at $60.9 million (down 39.1% YoY), while the FY2025 annual figure was $85.7 million, down 2.92% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $60.9 million, down from $85.7 million in the prior quarter.
- The five-year high for Cash & Equivalents was $143.8 million in Q1 2022, with the low at $60.9 million in Q1 2026.
- The 5-year median for Cash & Equivalents is $83.7 million (2024), against an average of $86.3 million.
- Peak annual rise in Cash & Equivalents reached 129.59% in 2022, while the deepest fall reached 52.31% in 2022.
- Ascend Wellness Holdings' Cash & Equivalents stood at $74.1 million in 2022, then decreased by 2.21% to $72.5 million in 2023, then gained by 21.72% to $88.3 million in 2024, then fell by 2.92% to $85.7 million in 2025, then decreased by 28.89% to $60.9 million in 2026.
- Business Quant data shows AAWH's Cash & Equivalents at $60.9 million in Q1 2026, $85.7 million in Q4 2025, and $87.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Ascend Wellness Holdings | 86.08 Mn | 19.08 Mn | 45.49 Mn | 67.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67.00 Mn |
| Mar 31, 2026 | 60.92 Mn |
| Dec 31, 2025 | 85.68 Mn |
| Sep 30, 2025 | 87.27 Mn |
| Jun 30, 2025 | 95.27 Mn |
| Mar 31, 2025 | 100.03 Mn |
| Dec 31, 2024 | 88.25 Mn |
| Sep 30, 2024 | 65.28 Mn |
| Jun 30, 2024 | 83.71 Mn |
| Mar 31, 2024 | 72.90 Mn |
| Dec 31, 2023 | 72.51 Mn |
| Sep 30, 2023 | 63.92 Mn |
| Jun 30, 2023 | 68.05 Mn |
| Mar 31, 2023 | 73.30 Mn |
| Dec 31, 2022 | 74.15 Mn |
| Sep 30, 2022 | 91.39 Mn |
| Jun 30, 2022 | 140.55 Mn |
| Mar 31, 2022 | 143.80 Mn |
| Dec 31, 2021 | 155.48 Mn |
| Mar 31, 2021 | 62.63 Mn |